Charles N. York II
2019
In 2019, Charles N. York II earned a total compensation of $1.1M as Chief Financial Officer and Vice President at Aeglea BioTherapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,000 |
|---|---|
| Salary | $390,000 |
| Stock Awards | $522,424 |
| Other | $7,712 |
| Total | $1,085,136 |
York received $522.4K in stock awards, accounting for 48% of the total pay in 2019.
York also received $165K in non-equity incentive plan, $390K in salary and $7.7K in other compensation.
Rankings
In 2019, Charles N. York II's compensation ranked 8,910th out of 13,971 executives tracked by ExecPay. In other words, York earned more than 36.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,910 out of 13,971 | 36th |
Division Manufacturing | 3,559 out of 5,695 | 38th |
Major group Chemicals And Allied Products | 1,343 out of 2,194 | 39th |
Industry group Drugs | 1,144 out of 1,880 | 39th |
Industry Pharmaceutical Preparations | 847 out of 1,392 | 39th |
Source: SEC filing on April 23, 2020.
York's colleagues
We found two more compensation records of executives who worked with Charles N. York II at Aeglea BioTherapeutics in 2019.